BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinder AJ, Edwards J, Samanta A, Nichol F. Pregnancy in a rheumatoid arthritis patient on infliximab and methotrexate. Rheumatology (Oxford). 2004;43:1195-1196. [PMID: 15317958 DOI: 10.1093/rheumatology/keh264] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther. 2005;21:733-738. [PMID: 15771759 DOI: 10.1111/j.1365-2036.2005.02405.x] [Cited by in Crossref: 196] [Cited by in F6Publishing: 156] [Article Influence: 12.3] [Reference Citation Analysis]
2 Papa A, Mocci G, Bonizzi M, Felice C, Andrisani G, De Vitis I, Guidi L, Gasbarrini A. Use of infliximab in particular clinical settings: management based on current evidence. Am J Gastroenterol. 2009;104:1575-1586. [PMID: 19491875 DOI: 10.1038/ajg.2009.162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
3 Berthelot JM, De Bandt M, Goupille P, Solau-Gervais E, Lioté F, Goeb V, Azaïs I, Martin A, Pallot-Prades B, Maugars Y. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine. 2009;76:28-34. [PMID: 19059799 DOI: 10.1016/j.jbspin.2008.04.016] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
4 Pham T, Bachelez H, Berthelot JM, Blacher J, Bouhnik Y, Claudepierre P, Constantin A, Fautrel B, Gaudin P, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Huet I, Jullien D, Launay O, Lemann M, Maillefert JF, Marolleau JP, Martinez V, Masson C, Morel J, Mouthon L, Pol S, Puéchal X, Richette P, Saraux A, Schaeverbeke T, Soubrier M, Sudre A, Tran TA, Viguier M, Vittecoq O, Wendling D, Mariette X, Sibilia J. TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine 2011;78 Suppl 1:15-185. [PMID: 21703545 DOI: 10.1016/S1297-319X(11)70001-X] [Cited by in Crossref: 53] [Cited by in F6Publishing: 5] [Article Influence: 5.3] [Reference Citation Analysis]
5 Mena-vazquez N. Safety of biologic therapies during pregnancy in women with rheumatic disease. WJR 2015;5:82. [DOI: 10.5499/wjr.v5.i2.82] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Clowse ME. The use of anti-TNFα medications for rheumatologic disease in pregnancy. Int J Womens Health 2010;2:199-209. [PMID: 21072312 DOI: 10.2147/ijwh.s6029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
7 Raja H, Matteson EL, Michet CJ, Smith JR, Pulido JS. Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding. Transl Vis Sci Technol 2012;1:6. [PMID: 24049706 DOI: 10.1167/tvst.1.2.6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
8 Marchioni RM, Lichtenstein GR. Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review. World J Gastroenterol. 2013;19:2591-2602. [PMID: 23674866 DOI: 10.3748/wjg.v19.i17.2591] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
9 Ali YM, Kuriya B, Orozco C, Cush JJ, Keystone EC. Can tumor necrosis factor inhibitors be safely used in pregnancy? J Rheumatol 2010;37:9-17. [PMID: 20008917 DOI: 10.3899/jrheum.090563] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
10 Lamboglia F, Dʼincà R, Oliva L, Bertomoro P, Sturniolo GC. Patient with Severe Crohnʼs Disease Became a Father While on Methotrexate and Infliximab Therapy: . Inflammatory Bowel Diseases 2009;15:648-9. [DOI: 10.1002/ibd.20722] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
11 Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum 2009;61:587-92. [PMID: 19404999 DOI: 10.1002/art.24462] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
12 Lioté F. Médicaments rhumatologiques autorisés pendant la grossesse. Revue du Rhumatisme 2005;72:755-60. [DOI: 10.1016/j.rhum.2005.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Lloyd M, Mcelhatton P, Carr M, Hall G, Hughes R. Methotrexate in pregnancy. Rheumatology 2005;44:697-697. [DOI: 10.1093/rheumatology/keh612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]